Nanoparticle conjugates of a highly potent toxin enhance safety and circumvent platinum resistance in ovarian cancer
Advanced-stage epithelial ovarian cancers are amongst the most difficult to treat tumors and have proven to be refractory to most cytotoxic, molecularly targeted, or immunotherapeutic approaches. Here, we report that nanoparticle-drug conjugates (NDCs) of monomethyl auristatin E (MMAE) significantly...
Main Authors: | , , , , , , , , , , , , , , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Published: |
Nature Publishing Group
2018
|
Online Access: | http://hdl.handle.net/1721.1/113634 https://orcid.org/0000-0001-5088-5810 https://orcid.org/0000-0003-3383-0118 https://orcid.org/0000-0002-2515-5602 |